Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Santen Pharmaceutical
- 22 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Sep 2016 New trial record